Paul Audhya
Chief Tech/Sci/R&D Officer at KALVISTA PHARMACEUTICALS, INC.
Net worth: 554 774 $ as of 2024-04-29
Paul Audhya active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KALVISTA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2021-05-02 | - |
Career history of Paul Audhya
Former positions of Paul Audhya
| Companies | Position | Start | End |
|---|---|---|---|
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 2018-11-25 | 2021-02-28 |
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 2016-01-31 | 2018-08-31 |
| HOSPIRA, INC. | Chief Tech/Sci/R&D Officer | 2013-05-31 | 2016-01-31 |
| REATA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2011-07-03 | - |
Training of Paul Audhya
| New York University | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Statistics
International
| United States | 8 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| KALVISTA PHARMACEUTICALS, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Private companies | 3 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
- Stock Market
- Insiders
- Paul Audhya
- Experience